Noradrenergic pathway

The noradrenergic pathway is a major neuromodulatory system in the central and peripheral nervous systems that utilizes norepinephrine (noradrenaline) as its primary signaling molecule (StatPearls, 2023). In the brain, the pathway originates primarily in the locus coeruleus and projects widely to the cortex, limbic system, and spinal cord, where it regulates arousal, vigilance, and the stress response (PubMed, PMID: 28854922). Peripherally, it is the cornerstone of the sympathetic nervous system, controlling 'fight-or-flight' responses such as increased heart rate and blood pressure (NIH, 2022). Rather than being a single protein target, the pathway comprises several distinct therapeutic targets, including alpha-1, alpha-2, and beta-adrenergic G protein-coupled receptors, as well as the norepinephrine transporter (NET) and metabolic enzymes like monoamine oxidase (UniProt, 2024). Dysregulation of this system is central to the pathophysiology of mood disorders, ADHD, and various cardiovascular conditions. Pharmacological interventions targeting this pathway include norepinephrine reuptake inhibitors for depression and ADHD, alpha-2 agonists for hypertension, and beta-blockers for cardiac arrhythmias and anxiety (PubChem, 2024).

Other names

Noradrenergic systemNorepinephrine pathwayNoradrenaline signaling systemAdrenergic system

Modulation of noradrenergic signaling through the inhibition of norepinephrine reuptake via the norepinephrine transporter (NET), activation or blockade of alpha- and beta-adrenergic receptors, and inhibition of catecholamine degradation enzymes such as monoamine oxidase (MAO).